4502 Takeda Pharmaceutical
- 4242.0
- +4.0+0.09%
Takeda Pharmaceutical News
Takeda Pharmaceutical: Internal Control Report - Period 147 (2023/04/01-2024/03/31)
Takeda Pharmaceutical: Regarding the partial correction of the convocation notice for the 148th regular shareholder meeting.
Takeda Pharmaceutical: Partial amendment of the listed matters in the "Notice of the 148th Ordinary Shareholders' Meeting Convening"
Takeda Pharmaceutical: Statement from the Chairman of the Board of Directors of Takeda Pharmaceuticals Sp Adr regarding the ISS voting rights exercise recommendation prior to the 148th regular shareholders' meeting.
Takeda Pharmaceutical: Opinions from Takeda Pharmaceuticals' Chairman of the Board, Akihiko Iijima, regarding the recommended exercise of voting rights by ISS for the 148th regular shareholders' meeting.
Takeda Pharmaceutical: 148th Annual General Meeting of Shareholders and Other Electronic Provision Measures
Takeda Pharmaceutical: Takeda Executive Remuneration Overview
Takeda Pharmaceutical: Executive compensation overview
Takeda Pharmaceutical: Message from President and CEO Christophe Weber
Takeda Pharmaceutical: Other items provided electronically at the 148th Annual General Meeting of Shareholders
Takeda Pharmaceutical: Notice of Convocation of the 148th Annual General Meeting of Shareholders and Meeting Materials
Takeda Pharmaceutical: Message from President and CEO Christophe Weber
Takeda Pharmaceutical: Notice of Convocation of the 148th Annual General Meeting of Shareholders and Shareholders' Meeting Materials
Takeda Pharmaceutical: Report on Corporate Governance 2023/12/14
Takeda Pharmaceutical: Report on Corporate Governance 2023/07/12
Takeda Pharmaceutical: Internal Control Report - 146th Period (2022/04/01 - 2023/03/31)
Takeda Pharmaceutical: (Corrected) Notice of Convocation of the 147th Ordinary General Meeting of Shareholders and Meeting
Takeda Pharmaceutical: Partial Correction to the Notice of Convocation of the 147th Ordinary General Meeting of Shareholders
Takeda Pharmaceutical: (Revised Edition) Notice of Convocation of the 147th Annual General Meeting of Shareholders and Shareholders' Meeting Materials
Takeda Pharmaceutical: Partial revisions to matters described in the “Notice of Convocation of the 147th Annual General Meeting of Shareholders”
Analysis
Price Target
No Data
